MedTrace Logo

Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART

NCT03986099 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 451

Last updated 2020-11-17

No results posted yet for this study

Summary

A randomized, open label trial of two strategies for Virus Load Differentiated Care (VLDC) monitoring of virologic outcome in a rural community based treatment program in Zimbabwe.

Conditions

  • ART
  • HIV I Infection

Interventions

DIAGNOSTIC_TEST

Monitoring virus load

Near point of care

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • Biomedical Research and Training Institute, Zimbabwe

    lead OTHER

Principal Investigators

  • Shungu Munyati, PhD · Biomedical Research and Training Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2020-06-15
Completion
2020-11-15

Countries

  • Zimbabwe

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03986099 on ClinicalTrials.gov